Cargando…

Riboflavin Supplementation in Patients with Crohn’s Disease [the RISE-UP study]

BACKGROUND AND AIMS: Crohn’s disease [CD] is characterised by chronic intestinal inflammation and dysbiosis in the gut. Riboflavin [vitamin B(2)] has anti-inflammatory, antioxidant and microbiome-modulatory properties. Here, we analysed the effect of riboflavin on oxidative stress, markers of inflam...

Descripción completa

Detalles Bibliográficos
Autores principales:	von Martels, Julius Z H, Bourgonje, Arno R, Klaassen, Marjolein A Y, Alkhalifah, Hassan A A, Sadaghian Sadabad, Mehdi, Vich Vila, Arnau, Gacesa, Ranko, Gabriëls, Ruben Y, Steinert, Robert E, Jansen, Bernadien H, Bulthuis, Marian L C, van Dullemen, Hendrik M, Visschedijk, Marijn C, Festen, Eleonora A M, Weersma, Rinse K, de Vos, Paul, van Goor, Harry, Faber, Klaas Nico, Harmsen, Hermie J M, Dijkstra, Gerard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303596/ https://www.ncbi.nlm.nih.gov/pubmed/31873717 http://dx.doi.org/10.1093/ecco-jcc/jjz208

Ejemplares similares

Riboflavin Supplementation Promotes Butyrate Production in the Absence of Gross Compositional Changes in the Gut Microbiota
por: Liu, Lei, et al.
Publicado: (2023)

Inulin-grown Faecalibacterium prausnitzii cross-feeds fructose to the human intestinal epithelium
por: Fagundes, Raphael R., et al.
Publicado: (2021)

A Combined Set of Four Serum Inflammatory Biomarkers Reliably Predicts Endoscopic Disease Activity in Inflammatory Bowel Disease
por: Bourgonje, Arno R., et al.
Publicado: (2019)

Anti-inflammatory Gut Microbial Pathways Are Decreased During Crohn’s Disease Exacerbations
por: Klaassen, Marjolein A Y, et al.
Publicado: (2019)

Long-Term Dietary Patterns Are Reflected in the Plasma Inflammatory Proteome of Patients with Inflammatory Bowel Disease
por: Bourgonje, Arno R., et al.
Publicado: (2022)

Hepcidin and Iron Status in Patients With Inflammatory Bowel Disease Undergoing Induction Therapy With Vedolizumab or Infliximab
por: Loveikyte, Roberta, et al.
Publicado: (2023)

A simple coculture system shows mutualism between anaerobic faecalibacteria and epithelial Caco-2 cells
por: Sadaghian Sadabad, Mehdi, et al.
Publicado: (2015)

Gut microbiota in inflammatory bowel diseases: moving from basic science to clinical applications
por: Collij, Valerie, et al.
Publicado: (2020)

Proteomic analyses do not reveal subclinical inflammation in fatigued patients with clinically quiescent inflammatory bowel disease
por: Bourgonje, Arno R., et al.
Publicado: (2022)

Serological Biomarkers of Extracellular Matrix Turnover and Neutrophil Activity Are Associated with Long-Term Use of Vedolizumab in Patients with Crohn’s Disease
por: Alexdottir, Marta S., et al.
Publicado: (2022)

Serological Biomarkers of Intestinal Collagen Turnover Identify Early Response to Infliximab Therapy in Patients With Crohn’s Disease
por: Alexdottir, Marta S., et al.
Publicado: (2022)

Whole exome sequencing analyses reveal gene–microbiota interactions in the context of IBD
por: Hu, Shixian, et al.
Publicado: (2021)

Use of Tumor Necrosis Factor-α Antagonists Is Associated With Attenuated IgG Antibody Response Against SARS-CoV-2 in Vaccinated Patients With Inflammatory Bowel Disease
por: Otten, Antonius T., et al.
Publicado: (2022)

Patients With Inflammatory Bowel Disease Show IgG Immune Responses Towards Specific Intestinal Bacterial Genera
por: Bourgonje, Arno R., et al.
Publicado: (2022)

Gut Microbiome Composition in Dystonia Patients
por: Timmers, Elze R., et al.
Publicado: (2023)

Mucosal Eosinophil Abundance in Non-Inflamed Colonic Tissue Is Associated with Response to Vedolizumab Induction Therapy in Inflammatory Bowel Disease
por: Gabriëls, Ruben Y., et al.
Publicado: (2022)

Polygenetic risk scores do not add predictive power to clinical models for response to anti-TNFα therapy in inflammatory bowel disease
por: Karmi, Naomi, et al.
Publicado: (2021)

Health-related quality of life is linked to the gut microbiome in kidney transplant recipients
por: Swarte, J. Casper, et al.
Publicado: (2023)

Serological biomarkers of type I, III and IV collagen turnover are associated with the presence and future progression of stricturing and penetrating Crohnʼs disease
por: Bourgonje, Arno R., et al.
Publicado: (2022)

Assessing intestinal permeability in Crohn’s disease patients using orally administered (52)Cr-EDTA
por: von Martels, Julius Z. H., et al.
Publicado: (2019)

Faecal metabolome and its determinants in inflammatory bowel disease
por: Vich Vila, Arnau, et al.
Publicado: (2023)

Donor genetic variants as risk factors for thrombosis after liver transplantation: A genome‐wide association study
por: Li, Yanni, et al.
Publicado: (2021)

The Composition and Metabolic Potential of the Human Small Intestinal Microbiota Within the Context of Inflammatory Bowel Disease
por: Ruigrok, Renate A A A, et al.
Publicado: (2021)

Large-scale genetic analyses in an understudied disease: haemorrhoidal disease
por: Festen, Eleonora A M, et al.
Publicado: (2021)

Environmental factors associated with biological use and surgery in inflammatory bowel disease
por: van der Sloot, Kimberley W J, et al.
Publicado: (2020)

Serum Free Thiols Are Superior to Fecal Calprotectin in Reflecting Endoscopic Disease Activity in Inflammatory Bowel Disease
por: Bourgonje, Arno R., et al.
Publicado: (2019)

Long-term dietary patterns are associated with pro-inflammatory and anti-inflammatory features of the gut microbiome
por: Bolte, Laura A, et al.
Publicado: (2021)

Donor tobacco smoking is associated with postoperative thrombosis after primary liver transplantation
por: Li, Yanni, et al.
Publicado: (2020)

Crohn’s Disease in Clinical Remission Is Marked by Systemic Oxidative Stress
por: Bourgonje, Arno R., et al.
Publicado: (2019)

Isotype-specific Antibody Responses to Mycobacterium avium paratuberculosis Antigens Are Associated With the Use of Biologic Therapy in Inflammatory Bowel Disease
por: van der Sloot, Kimberley W J, et al.
Publicado: (2020)

The emerging role of the small intestinal microbiota in human health and disease
por: Ruigrok, Renate A. A. A., et al.
Publicado: (2023)

Inflammation status modulates the effect of host genetic variation on intestinal gene expression in inflammatory bowel disease
por: Hu, Shixian, et al.
Publicado: (2021)

The Effect of Phenotype and Genotype on the Plasma Proteome in Patients with Inflammatory Bowel Disease
por: Bourgonje, Arno R, et al.
Publicado: (2021)

The role of the microbiome for human health: from basic science to clinical applications
por: Mohajeri, M. Hasan, et al.
Publicado: (2018)

Characteristics and Dysbiosis of the Gut Microbiome in Renal Transplant Recipients
por: Swarte, J. Casper, et al.
Publicado: (2020)

HIF1α-Dependent Induction of TFRC by a Combination of Intestinal Inflammation and Systemic Iron Deficiency in Inflammatory Bowel Disease
por: Fagundes, Raphael R., et al.
Publicado: (2022)

The 1000IBD project: multi-omics data of 1000 inflammatory bowel disease patients; data release 1
por: Imhann, Floris, et al.
Publicado: (2019)

Understanding human gut diseases at single-cell resolution
por: Bigaeva, Emilia, et al.
Publicado: (2020)

Analysis of microbial composition and sharing in low-biomass human milk samples: a comparison of DNA isolation and sequencing techniques
por: Spreckels, Johanne E., et al.
Publicado: (2023)

Correction to: The 1000IBD project: multi-omics data of 1000 inflammatory bowel disease patients; data release 1
por: Imhann, Floris, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_gfksd4gmmidim6t80ko75rokbo